Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Frequency Therapeutics, Inc. - Common Stock (NQ:FREQ)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Nov 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Frequency Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Why Did Bullfrog AI Stock Jump More Than 50%?
Trading volume and share price for BFRG took significant leaps forward on news the digital biopharmaceutical company will partner with Johns Hopkins University. 
Via MarketBeat
Topics Artificial Intelligence Initial Public Offering
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results
From Frequency Therapeutics, Inc.
Via Business Wire
Frequency Therapeutics to Participate at Upcoming March Investor Conferences
From Frequency Therapeutics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  OnThursday, 28 stocks made new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
 
Via Benzinga
Dow Gains Over 300 Points; S&P 500 Up 1%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 300 points on Monday. The Dow traded up 1.01% to 34,211.29 while the NASDAQ rose 1.52% to 11,896.33. The S&P 500... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday. 
Via Benzinga
Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded up 0.96% to 34,193.83 while the NASDAQ rose 1.52% to 11,896.75. The S&P 500... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 42 companies hit new 52-week lows. 
Via Benzinga
Frequency Therapeutics' Lead Hearing Loss Program Flunks, Shifts Focus To Multiple Sclerosis, Shares Plunge
 
Via Benzinga
US Stocks Open Higher; Dow Jumps 200 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.59% to 34,069.23 while the NASDAQ rose 0.65% to... 
Via Benzinga
Frequency Therapeutics Announces Topline Results for its Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss
From Frequency Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Frequency Therapeutics Announces Formation of Clinical Advisory Board for Remyelination in Multiple Sclerosis Program
From Frequency Therapeutics
Via Business Wire
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the... 
Via Benzinga
Frequency Therapeutics Announces First Patient Dosed in Phase 1b Study of FX-345, the Company’s Second Therapeutic Candidate for Sensorineural Hearing Loss
From Frequency Therapeutics, Inc.
Via Business Wire
Frequency Therapeutics to Host Virtual Investor Event, Highlighting Hearing Restoration Candidate FX-322 in Advance of Q1 Clinical Results
From Frequency Therapeutics, Inc.
Via Business Wire
Frequency Therapeutics Provides Business Updates and Third Quarter 2022 Financial Results
From Frequency Therapeutics, Inc.
Via Business Wire
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
Upgrades 
Via Benzinga
Frequency Therapeutics Completes Enrollment of Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss
From Frequency Therapeutics, Inc.
Via Business Wire
Frequency Therapeutics to Participate in September Investor and Medical Conferences
From Frequency Therapeutics, Inc.
Via Business Wire
Frequency Therapeutics Provides Business Updates and Second Quarter 2022 Financial Results
From Frequency Therapeutics, Inc.
Via Business Wire
Tesla, Twitter And 76 Biggest Movers From Friday
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.